At the peak of its growth in 2006, Amgen looked to expand its business even further. The market for biosimilars was lucrative, and the company only needed to join it at the right time. It carried out research and extensive market analysis of the venture to ensure it was a good move for the business.
What are the arguments for Amgen’s going into the biosimilar business?
Answer by Academic.tip's expert
An answer to this question is provided by one of our experts who specializes in business & economics. Let us know how much you liked it and give it a rating.
Cite this page
Select a citation style:
References
Academic.Tips. (2023) 'What are the arguments for Amgen's going into the biosimilar business'. 12 March.
Reference
Academic.Tips. (2023, March 12). What are the arguments for Amgen's going into the biosimilar business? https://academic.tips/question/what-are-the-arguments-for-amgens-going-into-the-biosimilar-business/
References
Academic.Tips. 2023. "What are the arguments for Amgen's going into the biosimilar business?" March 12, 2023. https://academic.tips/question/what-are-the-arguments-for-amgens-going-into-the-biosimilar-business/.
1. Academic.Tips. "What are the arguments for Amgen's going into the biosimilar business?" March 12, 2023. https://academic.tips/question/what-are-the-arguments-for-amgens-going-into-the-biosimilar-business/.
Bibliography
Academic.Tips. "What are the arguments for Amgen's going into the biosimilar business?" March 12, 2023. https://academic.tips/question/what-are-the-arguments-for-amgens-going-into-the-biosimilar-business/.
Work Cited
"What are the arguments for Amgen's going into the biosimilar business?" Academic.Tips, 12 Mar. 2023, academic.tips/question/what-are-the-arguments-for-amgens-going-into-the-biosimilar-business/.
Copy